Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: J Genet Couns. 2017 Nov 22;27(3):709–722. doi: 10.1007/s10897-017-0172-x

Figure 2.

Figure 2

Percentage of participants who had shared results with different types of people at 1 month and 12 months post-results disclosure stratified by those with PDR and those without. (chi squared test: no significant difference for any category)

Abbreviations: exome sequencing (ES) personal disease risk (PDR)